Through its Code of Practice for the Exploitation of Intellectual Property (IP), QMUL actively encourages the translation of academic research into commercial outputs. The IP exploitation process is implemented by “Innovation and Enterprise”, the technology transfer office at QMUL, consisting of a team with appropriate business and technology transfer experience and expertise. Innovation and Enterprise is active in developing commercial opportunities for a wide range of QMUL technologies. It has been responsible for negotiating and completing over 150 commercial and research contracts, including recent licensing deals with Biotech and Pharma. Where appropriate, QMUL also encourages IP exploitation with a number of existing spin-out companies that have been successful in attracting investment. In developing its companies, Innovation and Enterprise has adopted an approach which involves building a close working relationship between the founders, funders and technology transfer personnel.